PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Chiesi Farmaceutici S.p.A.

USPTO PatentsView assignee record — 189 granted patents across 30 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Explore the portfolio See the ranking
189
Total patents granted
30
CPC technology areas
15.9
Avg claims per patent
-36%
5-year filing velocity

The verdict

Chiesi holds 189 US patents across 30 technology areas — rank #2,088 of 50,000 tracked assignees.

#2,088
of 50,000 US assignees by volume
Top 12%
by Innovation Score (51.1/100)
15.9
avg claims per patent
-36%
filing velocity, last 5 yrs

Portfolio overview

Chiesi Farmaceutici S.p.A. has been granted 189 US utility patents between 2015 and 2025, placing Chiesi Farmaceutici S.p.A. at rank #2,088 across all assignees tracked by PlainPatent. This portfolio spans 30 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.9 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, Chiesi Farmaceutici S.p.A. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 51.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 74 grants, compared with 115 in the 2015–2019 window — a -36% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Chiesi Farmaceutici S.p.A.'s 15.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 30 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Chiesi Farmaceutici S.p.A. against peers pursuing similar technology classes.

How does Chiesi compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Chiesi holds 189 patents — placing it at rank #2,088 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

Chiesi's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

010203040 20152016201720182019202020212022202320242025 5
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Chiesi Farmaceutici S.p.A. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 29 15.3%
2016 29 15.3%
2017 16 8.5%
2018 28 14.8%
2019 13 6.9%
2020 20 10.6%
2021 18 9.5%
2022 16 8.5%
2023 11 5.8%
2024 4 2.1%
2025 5 2.6%

Which technologies does Chiesi Farmaceutici S.p.A. patent most?

Top 15 of 30 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#2,088

Across all tracked assignees

Innovation Score

51.1 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Chiesi Farmaceutici S.p.A. hold?
Chiesi Farmaceutici S.p.A. holds 189 US granted patents filed between 2015 and 2025, spanning 30 technology areas.
What is Chiesi Farmaceutici S.p.A.'s Innovation Score?
Chiesi Farmaceutici S.p.A. has an Innovation Score of 51.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Chiesi Farmaceutici S.p.A. focus on?
Chiesi Farmaceutici S.p.A.'s top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 144 patents. The company has filed patents in 30 CPC subclasses total.
Is Chiesi Farmaceutici S.p.A.'s patent filing rate increasing or decreasing?
Chiesi Farmaceutici S.p.A.'s recent filing velocity is -36% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Chiesi Farmaceutici S.p.A.'s patents?
Chiesi Farmaceutici S.p.A.'s patents average 15.9 claims each. This falls within the standard range, providing solid legal coverage.
How is the Chiesi Farmaceutici S.p.A. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How Innovation Score Works

Understand the four dimensions behind the composite score
How to Read Patent Data

Plain-English guide to CPC codes, claims, and metrics
Patent Moat Analysis

How companies use patents as competitive barriers

Explore the patent dataset

A61P technology

Chiesi Farmaceutici S.p.A.'s primary CPC class — all holders and yearly trends
Top 50 patent holders

See where Chiesi Farmaceutici S.p.A. ranks among the largest US patent assignees
All technology classes

Browse every CPC technology area by patent activity
How the score works

The four dimensions behind the Innovation Score

Related

All companies → | All technologies → | Rankings →
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology — how this data is sourced, computed, and verified.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope